Ambalal Sarabhai Enterprises Limited (BOM:500009)

Market Cap	2.48B -17.1%
Revenue (ttm)	2.02B +2.5%
Net Income	178.04M +261.0%
EPS	2.32 +262.5%
Shares Out	76.63M
PE Ratio	13.94
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,560
Open	32.60
Previous Close	33.39
Day's Range	32.00 - 33.72
52-Week Range	23.12 - 38.85
Beta	-0.00
Analysts	n/a
Price Target	n/a
Earnings Date	May 21, 2026

About BOM:500009

Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, markets, and supplies pharmaceutical products in India and internationally. The company offers products for oncology, infertility, and uro-gynaec areas; generic and veterinary products; antifungal active ingredient products; vitamin C coated products; and analytical, test, and measuring instruments, as well as supplies finished dosage forms and active pharmaceutical ingredients. It also provides broadcast and professional video/audio, and electronic products. Am...

• Industry: Pharmaceutical Preparations
• Founded: 1977
• Employees: 547
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500009

Financial Performance

In fiscal year 2026, BOM:500009's revenue was 2.02 billion, an increase of 2.50% compared to the previous year's 1.97 billion. Earnings were 178.04 million, an increase of 261.05%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 17, 2026

Data Sources Report a data error